The stock of Cipher Pharmaceuticals Inc (TSE:CPH) is a huge mover today! About 38,633 shares traded hands. Cipher Pharmaceuticals Inc (TSE:CPH) has declined 47.44% since April 29, 2016 and is downtrending. It has underperformed by 53.36% the S&P500.
The move comes after 8 months positive chart setup for the $107.02 million company. It was reported on Dec, 1 by Barchart.com. We have $4.12 PT which if reached, will make TSE:CPH worth $3.21M more.
Cipher Pharmaceuticals Inc (TSE:CPH) Ratings Coverage
Out of 2 analysts covering Cipher Pharmaceuticals (TSE:CPH), 1 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 50% are positive. Cipher Pharmaceuticals has been the topic of 2 analyst reports since August 12, 2016 according to StockzIntelligence Inc. The firm earned “Hold” rating on Friday, August 12 by GMP Securities. The rating was maintained by TD Securities on Friday, August 12 with “Buy”.
Another recent and important Cipher Pharmaceuticals Inc (TSE:CPH) news was published by Prnewswire.com which published an article titled: “Cipher Pharmaceuticals Inc. Announces Changes to its Board of Directors” on August 09, 2016.
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The company has a market cap of $107.02 million. The Firm has a portfolio of commercial and late-stage products. It currently has negative earnings. It operates in the specialty pharmaceuticals segment.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.